Principles of Contrast Enhanced Ultrasound

Contrast enhanced ultrasound uses microbubble agents to increase backscatter from blood and to provide real time assessment of vascularity and perfusion without ionizing radiation. Microbubbles remain intravascular and produce strong nonlinear echoes that specialized contrast modes detect while suppressing tissue signals. Contrast imaging includes arterial phase portal venous phase and late phase evaluation for focal liver lesions and can be applied to organ perfusion assessment and to characterization of masses. Proper contrast use requires intravenous access knowledge of injection protocols and familiarity with machine contrast presets and with low mechanical index imaging to preserve microbubble integrity.

Clinical Indications and Protocols

Common indications include characterization of focal liver lesions differentiation of benign from malignant nodules assessment of organ perfusion and guidance for targeted interventions. Protocols specify contrast dose injection rate and imaging windows and often include baseline gray scale and Doppler imaging for comparison. Real time cine capture during the arterial and portal phases documents enhancement patterns and washout characteristics that inform diagnosis. Contrast ultrasound is particularly valuable in patients with renal impairment or contrast allergy who cannot receive iodinated or gadolinium based agents and it complements cross sectional imaging in many clinical pathways.

Safety Monitoring and Documentation

Contrast agents used in ultrasound have favorable safety profiles but facilities maintain emergency response plans and staff training for rare hypersensitivity reactions. Screening for prior reactions and for relevant comorbidities is part of pre procedure preparation and documentation includes agent type dose lot number and timing of injection. Image archiving captures cine loops and representative frames for each phase and reports describe enhancement patterns and any limitations such as suboptimal acoustic windows. Quality assurance includes periodic review of contrast protocols and of clinical outcomes to ensure appropriate use and to refine local practice.